Insulin-like growth factor-I is a marker for the nutritional state

Pediatric Endocrinology Reviews

Volumn 13, Issue 2, 2015, Pages 499-511

  Hawkes, Colin P ^a,b,c   Grimberg, Adda ^a,d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c The National Children's Research Centre   (Ireland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Growth hormone; IGF 1; Nutrition; Obesity

Indexed keywords

BIOLOGICAL MARKER; GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE; PROTEIN INTAKE;

ADOLESCENCE; ARTICLE; CALORIC RESTRICTION; CHILD NUTRITION; CHILDHOOD; FETUS GROWTH; GROWTH HORMONE RELEASE; HIGH RISK POPULATION; HORMONAL REGULATION; HUMAN; MALABSORPTION; MALNUTRITION; NUTRITIONAL STATUS; OBESITY; OVERNUTRITION; PROTEIN RESTRICTION; SHORT STATURE; SIGNAL TRANSDUCTION; ADOLESCENT; BLOOD; CALORIC INTAKE; CHILD; FEMALE; FETUS DEVELOPMENT; INFANT; NEWBORN; PHYSIOLOGY; PREGNANCY; PRESCHOOL CHILD; PROTEIN INTAKE; SECRETION (PROCESS);

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DIETARY PROTEINS; ENERGY INTAKE; FEMALE; FETAL DEVELOPMENT; HUMAN GROWTH HORMONE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MALABSORPTION SYNDROMES; MALNUTRITION; NUTRITIONAL STATUS; OBESITY; OVERNUTRITION; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 85001544974     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (143)

1. Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr 2014; 164(Suppl 5):S1-e14-e16.
2. Juul A, Skakkebaek NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997;130(2):197-204.
3. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P, Lawson Wilkins Pediatric Endocrinology Society D, Therapeutics C. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003; 143(4):415-421.
4. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab 1994;78(5):1195- 1201.
5. Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res 2001;50(5):443-459.
6. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C. Regulation of in vivo growth hormone secretion by teptin. Endocrinology 1997;138(5):2203-2206.
7. Okada K, Sugihara H, Minami S, Wakabayashi I. Effect of parenteral administration of selected nutrients and central injection of gammaglobulin from antiserum to neuropeptide Y on growth hormone secretory pattern in food-deprived rats. Neuroendocrinology 1993;57(4):678-686.
8. Rettori V, Milenkovic L, Aguila MC, McCann SM. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 1990;126(5):2296-2301.
9. Maghnie M, Valtorta A, Moretta A, Larizza D, Preti P, Patladini G, Calcante S, Severi F. Diagnosing growth hormone deficiency: the value of short-term hypocaloric diet. J Clin Endocrinol Metab 1993;77(5):1372-1378.
10. Muller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, Batterham RL, Benoit SC, Bowers CY, Broglio F, Casanueva FF, D'Alessio D, Depoortere I, Geliebter A, Ghigo E, Cole PA, Cowley M, Cummings DE, Dagher A, Diano S, Dickson SL, Dieguez C, Granata R, Grill HJ, Grove K, Habegger KM, Heppner K, Heiman ML, Holsen L, Hoist B, Inui A, Jansson JO, Kirchner H, Korbonits M, Laferrere B, LeRoux CW, Lopez M, Morin S, Nakazato M, Nass R, Perez-Tilve D, Pfluger PT, Schwartz TW, Seeley RJ, Sleeman M, Sun Y, Sussel L, Tong J, Thorner MO, van der Lely AJ, van der Ploeg LH, Zigman JM, Kojima M, Kangawa K, Smith RG, Horvath T, Tschop MH. Ghrelin. Mol Metab 2015;4(6):437-460.
11. Miljic D, Pekic S, Djurovic M, Doknic M, Milic N, Casanueva FF, Ghatei M, Popovic V. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and Cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006;91 (4): 1491-1495.
12. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 2005;12(9):814-821.
13. Feigerlova E, Hwa V, Derr MA, Rosenfeld RG. Current issues on molecular diagnosis of GH signaling defects. Endocr Dev 2013;24:118-127.
14. Straus DS, Takemoto CD. Effect of fasting on insulin-like growth factor-l (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol 1990;4(1 ):91-100.
15. Maes M, Amand Y, Underwood LE, Maiter D, Ketelslegers JM. Decreased serum insulin-like growth factor I response to growth hormone in hypophysectomized rats fed a low protein diet: evidence for a postreceptor defect. Acta Endocrinol (Copenh) 1988; 117(3): 320-326.
16. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 2000;85(12):4712-4720.
17. Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 2010;95(1):369-374.
18. Guasti L, Silvennoinen S, Bulstrode NW, Ferretti P, Sankilampi U, Dunkel L. Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes. J Clin Endocrinol Metab 2014;99(11):E2198-E2206.
19. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 2008;8(1):77-83.
20. Gillum MP, Erion DM, Shulman Gl. Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med 2011; 17(1 ):8-13.
21. Amamoto M, Iguchi G, Fukuoka H, Suda K, Bando H, Takahashi M, Nishizawa H, Seino S, Takahashi Y. SIRT1 regulates adaptive response of the growth hormone-insulin-like growth factor-l axis under fasting conditions in liver. Proc Natl Acad Sci U S A 2013;110(37):14948-14953.
22. Cesur Y, Yordaman N, Dogan M. Serum insulin-like growth factor-l and insulin-like growth factor binding protein-3 levels in children with zinc deficiency and the effect of zinc supplementation on these parameters. J Pediatr Endocrinol Metab 2009;22(12): 1137-1143.
23. Dorup I, Flyvbjerg A, Everts ME, Clausen T. Role of insulin-like growth factor-1 and growth hormone in growth inhibition induced by magnesium and zinc deficiencies. Br J Nutr 1991;66(3):505-521.
24. Rao KS, Mohan PS. Plasma somatomedin activity, growth-hormone and insulin levels in vitamin B6 deficient rats. Horm Metab Res 1982;14(11):580-582.
25. Mehta A, Hindmarsh PC, Stanhope RG, Turton JP, Cole TJ, Preece MA, Oattani MT. The role of growth hormone in determining birth size and early postnatal growth, using congenital growth hormone deficiency (GHD) as a model. Clin Endocrinol (Oxf). 2005;63(2):223-231.
26. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335(18):1363-1367.
27. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29(3):219-225.
28. Bennett A, Wilson DM, Liu F, Nagashima R, Rosenfeld RG, Hintz RL. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocrinol Metab 1983;57(3):609-612.
29. Hansen-Pupp I, Lofqvist C, Polberger S, Niklasson A, Fellman V, Hellstrom A, Ley D. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res 2011;69(5 Pt 1 ):448-453.
30. Engstrom E, Niklasson A, Wikland KA, Ewald U, Hellstrom A. The role of maternal factors, postnatat nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 2005;57(4):605-610.
31. Kashyap S, Forsyth M, Zucker C, Ramakrishnan R, Dell RB, Heird WC. Effects of varying protein and energy intakes on growth and metabolic response in low birth weight infants. J Pediatr 1986; 108(6) :955-963.
32. Smith WJ, Underwood LE, Keyes L, Clemmons DR. Use of insulinlike growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants. J Clin Endocrinol Metab 1997;82(12):3982-3988.
33. de Zegher F, Sebastiani G, Diaz M, Gomez-Roig MD, Lopez-Bermejo A, Ibanez L. Breast-feeding vs formula-feeding for infants born small- for-gestational-age: divergent effects on fat mass and on circulating IGF-I and high-molecular-weight adiponectin in late infancy. J Clin Endocrinol Metab 2013;98(3):1242-1247.
34. de Zegher F, Sebastiani G, Diaz M, Sanchez-Infantes D, Lopez-Bermejo A, Ibanez L. Body composition and circulating high- molecular-weight adiponectin and IGF-I in infants born small for gestational age: breast- versus formula-feeding. Diabetes 2012;61(8):1969-1973.
35. Madsen AL, Larnkjaer A, Molgaard C, Michaelsen KF. IGF-I and IGFBP-3 in healthy 9 month old infants from the SKOT cohort: breastfeeding, diet, and later obesity. Growth Horm IGF Res 2011;21(4):199-204.
36. Hawkes CP, Grimberg A. Measuring growth hormone and insulin-tike growth factor-l in infants: what is normal? Pediatr Endocrinol Rev 2013; 11 (2): 126-146.
37. Hoppe C, Molgaard C, Dalum C, Vaag A, Michaelsen KF. Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys. Eur J Clin Nutr 2009;63(9):1076-1083.
38. Hoppe C, Molgaard C, Juul A, Michaelsen KF. High intakes of skimmed milk, but not meat, increase serum IGF-I and IGFBP-3 in eight-year- old boys. Eur J Clin Nutr 2004;58(9): 1211-1216.
39. Hoppe C, Molgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 2005;59(3):393-398.
40. Sen TA, Aycicek A. Do children with adenotonsillar hypertrophy have lower IGF-1 and ghrelin levels than the normal children? Int J Pediatr Otorhinolaryngol 2010;74(6):665-668.
41. Imamoglu S, Bereket A, Turan S, Taga Y, Haklar G. Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature. J Pediatr Endocrinol Metab 2005;18(1):69-74.
42. Ozon A, Alikasifoglu A, Yordam N. Influence of iodine supplementation on serum insulin-like growth factor-l (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. Turk J Pediatr 2004;46(4):303-308.
43. Angervo M, Toivonen J, Leinonen P, Valimaki M, Seppala M. Thyroxine withdrawal is accompanied by decreased circulating levels of insulinlike growth factor-binding protein-1 in thyroidectomized patients. J Clin Endocrinol Metab 1993;76(5):1199-1201.
44. Miell JP, Zini M, Quin JD, Jones J, Portioli I, Valcavi R. Reversible effects of cessation and recommencement of thyroxine treatment on insulinlike growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy. J Clin Endocrinol Metab 1994;79(5):1507-1512.
45. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academies Press 2005.
46. Soliman A, De Sanctis V, Elalaily R. Nutrition and pubertal development. Indian J Endocrinol Metab 2014;18(Suppl 1):S39-S47.
47. Elias CF, Purohit D. Leptin signaling and circuits in puberty and fertility. Cellular and molecular life sciences. CMLS 2013;70(5):841-862.
48. Mann DR, Plant TM. Leptin and pubertal development. Semin Reprod Med 2002;20(2):93-102.
49. Food and Agriculture Organization of the United Nations, International Fund for Agriculture Development, World Food Programme. The state of food insecurity in the world Rome 2014.
50. Gundersen C. Food insecurity is an ongoing national concern. Adv Nutr 2013;4(1):36-41.
51. Stephens LD, McNaughton SA, Crawford D, MacFarlane A, Ball K. Correlates of dietary resilience among socioeconomically disadvantaged adolescents. Eur J Clin Nutr 2011;65(11): 1219-1232.
52. Cook JT, Black M, Chilton M, Cutts D, Ettinger de Cuba S, Heeren TC, Rose-Jacobs R, Sandel M, Casey PH, Coleman S, Weiss I, Frank DA. Are food insecurity's health impacts underestimated in the US population? Marginal food security also predicts adverse health outcomes in young US children and mothers. Adv Nutr 2013;4(1):51-61.
53. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-l (IGF-I) and IGF- binding proteins in children and adults. J Clin Endocrinol Metab 1995;80(2):443-449.
54. Moses N, Banilivy MM, Lifshitz F. Fear of obesity among adolescent girls. Pediatrics 1989;83(3):393-398.
55. Pugliese MT, Lifshitz F, Grad G, Fort P, Marks-Katz M. Fear of obesity. A cause of short stature and delayed puberty. N Engl J Med 1983;309(9):513-518.
56. Lifshitz F, Moses N. Nutritional dwarfing: growth, dieting, and fear of obesity. J Am Coll Nutr 1988;7(5):367-376.
57. Romano C, Hartman C, Privitera C, Cardile S, Shamir R. Current topics in the diagnosis and management of the pediatric non organic feeding disorders (NOFEDs). Clin Nutr 2015;34(2):195-200.
58. Thomas R, Sanders S, Doust J, Better E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 2015;135(4):e994-e1001.
59. Davis C, Fattore L, Kaplan AS, Carter JC, Levitan RD, Kennedy JL. The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults. Int J Neuropsychopharmacol 2012;15(2):181-187.
60. Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Horm Res 2005;63(4):159-164.
61. Lopez-Varela S, Montero A, Chandra RK, Marcos A. Nutritional status of young female elite gymnasts. Int J Vitam Nutr Res 2000;70(4):185-190.
62. Iglesias-Gutierrez E, Garcia-Roves PM, Rodriguez C, Braga S, Garcia- Zapico P, Patterson AM. Food habits and nutritional status assessment of adolescent soccer players. A necessary and accurate approach. Can JAppl Physiol 2005;30(1):18-32.
63. Weimann E, Witzel C, Schwidergall S, Bohles HJ. Peripubertal perturbations in elite gymnasts caused by sport specific training regimes and inadequate nutritional intake. Int J Sports Med 2000;21(3):210-215.
64. Gibson JC, Stuart-Hill L, Martin S, Gaul C. Nutrition status of junior elite Canadian female soccer athletes. Int J Sport Nutr Exerc Metab 2011;21(6):507-514.
65. Deimel JF, Dunlap BJ. The female athlete triad. Clin Sports Med 2012;31(2):247-254.
66. Nichols JF, Rauh MJ, Lawson MJ, Ji M, Barkai HS. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med 2006;160(2):137-142.
67. De Souza MJ, Williams Nl. Beyond hypoestrogenism in amenorrheic athletes: energy deficiency as a contributing factor for bone loss. Curr Sports Med Rep 2005;4(1):38-44.
68. Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constantini N, Lebrun C, Meyer N, Sherman R, Steffen K, Budgett R, Ljungqvist A. The IOC consensus statement: beyond the Female Athlete Triad-Relative Energy Deficiency in Sport (RED-S). Br J Sports Med 2014;48(7):491-497.
69. Adiyaman P, Ocal G, Berberoglu M, Evliyaoglu O, Aycan Z, Cetinkaya E, Bulca Y, Ersoz G, Akar N. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-l/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts. J Pediatr Endocrinol Metab 2004; 17(6):895-903.
70. Ahmed SF, Farquharson C. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol 2010;206(3):249-259.
71. MacRae VE, Wong SC, Farquharson C, Ahmed SF. Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases (review). Int J Mol Med 2006;18(6):1011-1018.
72. Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, Ballati G, Boscherini B. Short stature as the primary manifestation of monosymptomatic celiac disease. J Pediatr Gastroenterol Nutr 1992;14(1):12-16.
73. Gasparetto M, Guariso G. Crohn's disease and growth deficiency in children and adolescents. World J Gastroenterol 2014;20(37):13219-13233.
74. Jansson UH, Kristiansson B, Magnusson P, Larsson L, Albertsson-Wikland K, Bjarnason R. The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease. Eur J Endocrinol 2001;144(4):417-423.
75. Locuratolo N, Pugliese G, Pricci F, Romeo G, Mariani P, Diaz-Horta O, Calvani L, Montuori M, Cipotletta E, Di Mario U, Bonamico M. The circulating insulin-like growth factor system in children with coeliac disease: an additional marker for disease activity. Diabetes Metab Res Rev 1999; 15(4): 254-260.
76. Street ME, Volta C, Ziveri MA, Zanacca C, Banchini G, Viani I, Rossi M, Virdis R, Bernasconi S. Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin Endocrinol (Oxf) 2008;68(1):22-28.
77. Valdimarsson T, Arnqvist HJ, Toss G, Jarnerot G, Nystrom F, Strom M. Low circulating insulin-like growth factor I in coeliac disease and its relation to bone mineral density. Scand J Gastroenterol 1999;34(9):904-908.
78. Ferrante E, Giavoli C, Elli L, Redaetli A, Novati E, De Bellis A, Ronchi CL, Bergamaschi S, Lania A, Bardella MT, Bellastella G, Beck-Peccoz P. Evaluation of GH-IGF-I axis in adult patients with coeliac disease. Horm Metab Res 2010;42(1):45-49.
79. Soliman AT, Hassan AE, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 1986;20(11):1122-1130.
80. Giovenale D, Meazza C, Cardinale GM, Sposito M, Mastrangelo Messini B, Citro G, Delvecchio M, Di Maio S, Bozzola M. The prevalence of growth hormone deficiency and celiac disease in short children. Clin Med Res 2006;4(3):180-183.
81. Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. J Pediatr Gastroenterol Nutr 2007;45(4):433-437.
82. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Mertin B, Lerebours E, Savoye G, Salomez JL, Cortot A, Colombel JF, Turck D. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Am J Gastroenterol 2010;105(8): 1893-1900.
83. Corkins MR, Gohil AD, Fitzgerald JF. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003;36(2):228-234.
84. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982;55(5):999-1002.
85. Grinspoon SK, Baum HB, Peterson S, Klibanski A. Effects of rhIGF-l administration on bone turnover during short-term fasting. J Clin Invest 1995;96(2):900-906.
86. Gat-Yablonski G, Shtaif B, Abraham E, Phillip M. Nutrition-induced catch-up growth at the growth plate. J Pediatr Endocrinol Metab 2008;21(9):879-893.
87. McLaren DS, Pellett PL, Read WW. A simple scoring system for classifying the severe forms of protein-calorie malnutrition of early childhood. Lancet 1967;1(7489):533-535.
88. Hintz RL, Suskind R, Amatayakul K, Thanangkul O, Olson R. Plasma somatomedin and growth hormone values in children with protein- calorie malnutrition. J Pediatr 1978;92(1): 153-156.
89. Kouanda S, Doulougou B, De Coninck V, Habimana L, Sondo B, Tonglet R, Ketelslegers JM, Robert A. Insulin Growth Factor-I in Protein-Energy Malnutrition during Rehabilitation in Two Nutritional Rehabilitation Centres in Burkina Faso. J Trop Med 2009;2009:832589.
90. Caregaro L, Favaro A, Santonastaso P, Alberino F, Di Pascoli L, Nardi M, Favaro S, Gatta A. Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders. Clin Nutr 2001;20(3):251-257.
91. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu- Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar Ml, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov W, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384(9945):766-781.
92. Singh GK, Kogan MD, van Dyck PC. Changes in state-specific childhood obesity and overweight prevalence in the United States from 2003 to 2007. Arch Pediatr Adolesc Med 2010; 164(7): 598-607.
93. Aksglaede L, Juul A, Olsen LW, Sorensen Tl. Age at puberty and the emerging obesity epidemic. PLoS One 2009;4(12):e8450.
94. Vignolo M, Naselti A, Di Battista E, Mostert M, Aicardi G. Growth and development in simple obesity. Eur J Pediatr 1988;147(3):242-244.
95. He Q, Karlberg J. Bmi in childhood and its association with height gain, timing of puberty, and final height. Pediatr Res 2001;49(2):244-251.
96. Denzer C, Weibel A, Muche R, Karges B, Sorgo W, Wabitsch M. Pubertal development in obese children and adolescents. Int J Obes (Lond) 2007;31(10):1509-1519.
97. Papadimitriou A, Gousi T, Giannouli O, Nicolaidou P. The growth of children in relation to the timing of obesity development. Obesity 2006;14(12):2173-2176.
98. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half- life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73(5): 1081 -1088.
99. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991;72(1):51-59.
100. Loche S, Cappa M, Borrelli P, Faedda A, Crino A, Cella SG, Corda R, Muller EE, Pintor C. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol (Oxf) 1987;27(2):145-153.
101. Patel L, Skinner AM, Price DA, Clayton PE. The influence of body mass index on growth hormone secretion in normal and short statured children. Growth Regul 1994;4(1):29-34.
102. Stanley TL, Levitsky LL, Grinspoon SK, Misra M. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab 2009;94(12):4875-4881.
103. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 1984;311(22):1403-1407.
104. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Effect of obesity on total and free insulin-like growth factor (IGF)- 1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone Int J Obes Relat Metab Disord. 1997;21(5):355-359.
105. Radetti G, Bozzola M, Pasquino B, Paganini C, Aglialoro A, Livferi C, Barreca A. Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children. Metabolism 1998;47(12):1490-1493.
106. Schneider HJ, Sailer B, Klotsche J, Marz W, Erwa W, Wittchen HU, Stalla GK. Opposite associations of age-dependent insulin-like growth factor-l standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 2006;154(5):699-706.
107. Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA, Hernandez M. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 1997;82(7):2076-2083.
108. Roman R, Iniguez G, Lammoglia JJ, Avila A, Salazar T, Cassorla F. The IGF-I response to growth hormone is related to body mass index in short children with normal weight. Horm Re 2009;72(1):10-14.
109. Mohammadzadeh G, Zarghami N. Serum leptin level is reduced in non-obese subjects with type 2 diabetes. Int J Endocrinol Metab 2013;11(1 ):3-10.
110. Ostadrahimi A, Moradi T, Zarghami N, Shoja MM. Correlates of serum leptin and insulin-like growth factor-l concentrations in normal weight and overweight/obese Iranian women. J Womens Health (Larchmt) 2008;17(8):1389-1397.
111. Haspolat K, Ece A, Gurkan F, Atamer Y, Tutanc M, Yolbas I. Relationships between leptin, insulin, IGF-1 and IGFBP-3 in children with energy malnutrition. Clin Biochem 2007;40(3-4):201-205.
112. Ajuwon KM, Kuske JL, Ragland D, Adeola O, Hancock DL, Anderson DB, Spurlock ME. The regulation of IGF-1 by leptin in the pig is tissue specific and independent of changes in growth hormone. J Nutr Biochem 2003;14(9):522-530.
113. Houseknecht KL, Portocarrero CP, Ji S, Lemenager R, Spurlock ME. Growth hormone regulates leptin gene expression in bovine adipose tissue: correlation with adipose IGF-1 expression. J Endocrinol 2000;164(1):51-57.
114. Kishida Y, Hirao M, Tamai N, Nampei A, Fujimoto T, Nakase T, Shimizu N, Yoshikawa H, Myoui A. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone 2005;37(5):607-621.
115. Wang L, Shao YY, Ballock RT. Leptin synergizes with thyroid hormone signaling in promoting growth plate chondrocyte proliferation and terminal differentiation in vitro. Bone 2011;48(5): 1022-1027.
116. Blethen SL, Weldon VV. Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sci 1986;292(1):21-24.
117. Geffner ME, Lippe BM, Bersch N, Van Herle A, Kaplan SA, Elders MJ, Golde DW. Growth without growth hormone: evidence for a potent circulating human growth factor. Lancet 1986;1(8477):343-347.
118. Reinehr T, Panteliadou A, de Sousa G, Andler W. Insulin-like growth factor-l, insulin-like growth factor binding protein-3 and growth in obese children before and after reduction of overweight. J Pediatr Endocrinol Metab 2009;22(3):225-233.
119. Hosick PA, McMurray RG, Hackney AC, Battaglini CL, Combs TP, Harrell JS. Differences in the GH-IGF-I axis in children of different weight and fitness status. Growth Horm IGF Res 2012;22(2):87-91.
120. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995;44(10 Suppl 4): 37-44.
121. Katz LE, DeLeon DD, Zhao H, Jawad AF. Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1. J Clin Endocrinol Metab 2002;87(6):2978-2983.
122. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348(17):1625-1638.
123. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371{9612):569-578.
124. Demarfc-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, Ganz PA, Rock CL, Schmitz KH, Wadden T, Philip EJ, Wolfe B, Gapstur SM, Ballard-Barbash R, McTiernan A, Minasian L, Nebeling L, Goodwin PJ. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 2012;21(8):1244-1259.
125. Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology 2014;146(2):357-373.
126. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83(8):2730-2734.
127. Steuerman R, Shevah O, Laron Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur J Endocrinol 2011;164(4):485-489.
128. Shevah O, Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res 2007;17(1):54-57.
129. Samani AA, Yakar S, LeRoith D, Brodt P. The rote of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007;28(1):20-47.
130. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab 2015;100(3):911-919.
131. Sirmans SM, Parish RC, Blake S, Wang X. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population. J Investig Med 2014;62(6):868-874.
132. Webber U, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003;362(9389):1017-1021.
133. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008;14(4):367-378.
134. Kaltsas GA, Androulakis, II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G. Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol (Oxf) 2007;67(6):917-922.
135. Stubbs SA, Webber U, Stark J, Rice S, Margara R, Lavery S, Trew GH, Hardy K, Franks S. Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries. J Clin Endocrinol Metab 2013;98(8):3298-3305.
136. E, Tassoni P, Cicognani A, Pirazzoli P, Salardi S, Balsamo A, Cassio A, Zucchini S, Colli C, Tassinari D. Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinot Metab 1994;79(6):1663-1669.
137. Tassoni P, Cacciari E, Cau M, Colli C, Tosi M, Zucchini S, Cicognani A, Pirazzoli P, Salardi S, Balsamo A, Frejaville E, Cassio A, Zappulla F. Variability of growth hormone response to pharmacological and sleep tests performed twice in short children. J Clin Endocrinol Metab 1990;71(1):230-234.
138. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinot Metab 1996;81(9):3323-3327.
139. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994;79(2):537-541.
140. Shalet SM. Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist. Eur J Endocrinol 2013;169(4):R81-R87.
141. Carel JC, Ecosse E, Landier F, Meguellati-Hakkas D, Kaguelidou F, Rey G, Coste J. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab 2012;97(2):416-425.
142. Poidvin A, Touze E, Ecosse E, Landier F, Bejot Y, Giroud M, Rothwell PM, Carel JC, Coste J. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurology 2014; 83 (9) :780-786.
143. Livingstone C. The insulin-like growth factor system and nutritional assessment. Scientifica (Cairo) 2012;2012:768731.